AETHLON MEDICAL INC (AEMD) Stock Price
AEMDStock
$2.49−97.56%52W
Market Cap$1.77M
P/E—
PEG Ratio—
Div yield—
Beta1.52
AEMD Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-87.08%
Price vs S&P 500 (4W)-26.77%
VGM Score51.11
AEMD Earnings Surprise History
| Quarter | Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|---|
| Q2 2026 | -$4.05 | -$4.02 | +0.74%(+$0.03) | |
| Q4 2025 | -$10.05 | -$12.25 | -21.89%(-$2.20) | |
| Q3 2025 | -$8.47 | -$18.70 | -120.65%(-$10.23) | |
| Q2 2025 | -$36.50 | -$42.50 | -16.44%(-$6.00) |
AEMD Analyst Recommendations
May 2026
Jun 2026
Jul 2026
Aug 2026
2.29
2.29
2.29
2.29
Industry Peers — Surgical & Medical Instruments(140)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
AEMDAETHLON MEDICAL INC | — | A | F | $2.49 |
| SYKStryker Corporation | C | B | C | $330.69 |
| MMM3M Company | C | D | C | $174.34 |
| BSXBoston Scientific Corp. | C | B | D | $46.84 |
| BDXBecton, Dickinson and Co. | B | D | B | $189.52 |
| MDLNMedline Inc. Class A common stock | C | D | C | $35.28 |
| RMDResMed Inc. | C | B | B | $240.33 |
| DXCMDexCom, Inc. | D | B | B | $90.82 |
| WSTWest Pharmaceutical Services, Inc. | D | C | B | $337.47 |
| SOLVSolventum Corporation | C | C | B | $91.12 |
| BAXBaxter International Inc. | B | D | B | $26.13 |
About AETHLON MEDICAL INC
Aethlon Medical is a medical device company developing the Hemopurifier, a clinical-stage therapeutic device designed to remove cancer cells and life-threatening viruses from the circulatory system. The platform addresses significant unmet needs in cancer treatment and biodefense through novel blood purification technology.